COMMUNIQUÉS West-GlobeNewswire

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

04/03/2025 - 22:01

SAN DIEGO, March 04, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]

Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025

04/03/2025 - 21:53

Oak Ridge, TN, March 04, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will host an investor conference call on Thursday, March 6 [...]

BioPorto A/S announces Jens Due Olsen as a Board of Directors candidate intending to appoint Jens Due Olsen as Chair, along with updates on other candidates

04/03/2025 - 21:28

March 4, 2025 Announcement no. 04 BioPorto A/S announces Jens Due Olsen as a Board of Directors candidate intending to appoint Jens Due Olsen as Chair, along with updates on other candidates COPENHAGEN, DENMARK, March 4 [...]

NanoNewron Appoints Industry Veteran Marco Taglietti, M.D., as Chief Executive Officer to Lead the Company and the Development of Their Promising Alzheimer’s Compound

04/03/2025 - 21:13

UNION, N.J., March 04, 2025 (GLOBE NEWSWIRE) -- NanoNewron, LLC (“NanoNewron” or the “Company”), a pioneering biotechnology company developing innovative, humanized biologics that cross the blood-brain barrier (BBB) to [...]

Plus Therapeutics Secures Private Placement of Approximately $15 Million in Gross Proceeds

04/03/2025 - 20:06

HOUSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics , Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for [...]

Eurobio Scientific : résiliation du contrat de liquidité

04/03/2025 - 20:03

RÉSILIATION DU CONTRAT DE LIQUIDITÉ Paris, le 4 mars 2025 –19h50 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro et les sciences de la vie, annonce [...]

NKGen Biotech, Inc. to Transition from the Nasdaq Global Market to OTC Markets; Reverse Stock Split will not be Implemented

04/03/2025 - 19:00

Trading commencing on the OTC Markets on March 5, 2025. Trading expected to continue under ticker symbol “NKGN” for common stock and “NKGNW” for warrants. NKGen Biotech, Inc. (“NKGen” or the “Company”) has regained [...]

USAHS Doctor of Physical Therapy Program in Austin Offers Free Basic Screening Services to the Austin Community

04/03/2025 - 18:58

USAHS furthers its commitment to the Austin community by offering accessible physical therapy screening services led by students and faculty. AUSTIN, Texas, March 04, 2025 (GLOBE NEWSWIRE) -- The University of St. [...]

Iridia Makes History: First Cryptocurrency and Molecular Off-World Data Archive Successfully Lands on the Moon

04/03/2025 - 18:00

Groundbreaking Molecular Data Technology Establishes Humanity's First Permanent Lunar Data Repository Using Molecular Storage SAN DIEGO, March 04, 2025 (GLOBE NEWSWIRE) -- Iridia, the pioneering molecular technology [...]

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

04/03/2025 - 17:58

Company Announcement COPENHAGEN, Denmark; March 4, 2025 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document [...]

Lirum Therapeutics Presents Positive Data on LX-101 at the 2025 ESMO Targeted Anticancer Therapies Congress; Highlighting LX-101’s Promise in IGF-1R Prominent Cancers

04/03/2025 - 16:30

New York, NY, March 04, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today the [...]

Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN®

04/03/2025 - 16:00

ST. LOUIS, March 04, 2025 (GLOBE NEWSWIRE) -- Optime Care , a nationally recognized specialty pharmacy and an AscellaHealth Company, today announces an expanded partnership with Eton Pharmaceuticals (“Eton”), an [...]

Verana Health Enhances Site Explorer Tool to Advance Diversity in Clinical Trials

04/03/2025 - 16:00

Exclusive data access and expanded functionality allows trial sponsors and contract research organizations (CROs) to enhance inclusive representation, improve clinical trial enrollment, and strengthen evidence SAN [...]

Better Choice Company Appoints Renowned Expert in Rare and Undiagnosed Diseases, Dr. Paldeep S. Atwal, as its United States Special Healthcare Advisor

04/03/2025 - 16:00

TAMPA, Fla., March 04, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced the appointment of Dr. Paldeep S. [...]

H.H.C. Group Highlights Flat-Fee Approach to Dialysis Claim Review, Unveils Cost-Saving Case Study for March Kidney Month

04/03/2025 - 15:58

ROCKVILLE, Md., March 04, 2025 (GLOBE NEWSWIRE) -- Recognizing March as National Kidney Month , H.H.C. Group (H.H.C.), the leader in reducing healthcare costs by providing high-quality cost containment using claim [...]

Pharming Group reports on results of the 2025 Extraordinary General Meeting of Shareholders

04/03/2025 - 15:15

Leiden, the Netherlands, March 4, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today that the Extraordinary General Meeting of Shareholders (EGM) has adopted [...]

Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum

03/03/2025 - 22:48

MELBOURNE, Australia and INDIANAPOLIS, March 04, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) invites investors to join a webinar showcasing the Company’s late-stage [...]

FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results

03/03/2025 - 22:45

SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce fourth quarter and full year 2024 financial results on Monday, March 17 after the markets close. FibroGen will also conduct a [...]

23andMe Special Committee Rejects Acquisition Proposal From CEO Anne Wojcicki

03/03/2025 - 22:35

SUNNYVALE, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- The Special Committee of the Board of Directors of 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME) today confirmed receipt of a non-binding proposal [...]